Highlights Newsletter 2

This newsletter presents you the following key sessions:

1. Podcast with Prof. Steven Pipe about the results from HOPE-B evaluating gene therapy in adult patients with
   severe or moderately severe haemophilia B

2. Ruxolitinib effective in polycythemia vera patients with or without splenomegaly

3. Luspatercept outperforms epoetin alfa in transfusion-dependent, lower-risk myelodysplastic syndromes

4. Ibrutinib plus venetoclax with MRD-directed duration of treatment as a potential novel standard of care for
    previously untreated CLL